Todd W. Garner Power - 31 Oct 2025 Form 4 Insider Report for CONMED Corp (CNMD)

Reporting relationship: Executive Vice President & CFO
Issuer ticker: CNMD
Reported as of: 31 Oct 2025
Net transaction value: -$95,216
SEC form: 4
Accepted by SEC: 03 Nov 2025, 16:47:47 UTC
Prior SEC filing: 08 Aug 2025
Next SEC filing: 07 Nov 2025
Source filing: View source filing
Reporting owner signature: /s/ Thomas Fistek for Todd W. Garner by Power of Attorney

Key filing fact

Todd W. Garner Power filed Form 4 for CONMED Corp (CNMD) on 03 Nov 2025.

Key facts

This page summarizes Todd W. Garner Power's Form 4 filing for CONMED Corp (CNMD).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 03 Nov 2025, 16:47.

Change

Previous filing in this sequence was filed on 08 Aug 2025.
Current net transaction value: -$95,216.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001726884 Primary reporting owner

Garner Todd W

Relationship: Executive Vice President & CFO
Address: C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO
Signature: /s/ Thomas Fistek for Todd W. Garner by Power of Attorney
Signature date: 03 Nov 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CNMD transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +7,500
Change %
Price: $0.000000
Shares after: 7,500
Date: 31 Oct 2025
Ownership: Direct

CNMD transaction

Common Stock

Tax liability

Transaction value: $95,216
Shares: -2,164
Change %: -29%
Price: $44.00
Shares after: 5,336
Date: 31 Oct 2025
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CNMD transaction Derivative

RSUs (Restricted Stock Units)

Options Exercise

Transaction value: $0
Shares: -7,500
Change %: -33%
Price: $0.000000
Shares after: 15,227
Date: 31 Oct 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,500
Exercise price
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company").

Footnote F2

The RSUs are subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan vesting over two years with 33% vesting after year 1 and 67% vesting after year 2.